近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
article
Full Text
OpenAlex
2388
FWCI436.6362
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
article
Full Text
OpenAlex
1382
FWCI446.7241
The hallmarks of cancer metabolism: Still emerging
review
Full Text
OpenAlex
1326
FWCI118.2875
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
review
Full Text
OpenAlex
948
FWCI114.5665
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
review
Full Text
OpenAlex
943
FWCI119.8266
New insights into activation and function of the AMPK
review
Full Text
OpenAlex
904
FWCI68.3822
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
article
Full Text
OpenAlex
845
FWCI97.9686
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
review
Full Text
OpenAlex
792
FWCI117.7143
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
review
Full Text
OpenAlex
750
FWCI62.2287
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
article
Full Text
OpenAlex
742
FWCI87.3061